| Name | Title | Contact Details |
|---|
Heart Force Medical Inc. (HFM), a private company, has invented and has patents pending for the digital Ballistocardiograph (dBG(TM)). The dBG 300, which is already approved in Canada and the United States, captures the movement of the heart during each cardiac cycle (heart beat). This movement (acceleration and force) is sensed by an accelerometer aligned to the three principal axes and displayed on a computer screen using HFM's proprietary software. Preliminary evaluation has determined that a 10-30 second recording of the dBG waveform is sufficient for a detailed analysis of cardiac performance. The Heart Force dBG 300 device is a non-invasive, standalone, portable unit and contains sophisticated digital sensors and proprietary software.
Verathon (formerly Diagnostic Ultrasound Corporation) designs, manufactures and distributes reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community.
Biomed Pharmaceuticals is a Sharon Hill, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The only independent, free standing, non-profit home health care and hospice agency serving the South Shore, NVNA and Hospice provides care to over 27 communities from Milton to Plymouth. Ten-time winner of the national HomeCare Elite Top Agency award, Top 100 the last two years, NVNA and Hospice offers the full continuum of care from certified and private pay home care, to palliative and hospice care. Non-profit hospice residence, the Pat Roche Hospice Home, offers residential hospice care. Specialty services in Alzheimer`s, Diabetes, CHF, Chronic Disease Self Management, Wound Care, and Falls Prevention. Educational programs, free health screenings, and caregiver support groups also offered.
Clin-X, comprised of three affiliated companies (ClinEdge, BTC Network, and GuideStar Research), provides a full range of clinical and outsourced business services to clinical research institutions, hospitals, pharmaceutical companies, and CROs. Combined, the companies represent four business segments: two global networks of research clinics, consulting and financial management, and patient recruitment and retention. The business segments seamlessly work together to streamline research operations, minimize enrollment timelines, and overall help research institution businesses thrive.